27 research outputs found
Teknologia mekanikoaren euskal lexikogintza
No full textEstudio del léxico mecánico vasco hasta nuestros días dividido en tres partes: hasta el siglo XX, hasta 1936 y hasta hoy en día. También hay una bibliografía sobre el tema. Al referirse a la mecánica, el autor no se refiere a la rama de la física de ese nombre, sino a máquinas, materiales, etcThe author studies the Basque mechanical lexicon splitting it into three parts: up to the 20th century, up to 1936 and up to the present day. There is also a Bibliography on the subject. Reference to mechanics, the author does not refer to the branch of physics of that name, but to machines, materials, etc
¿Es hora de revisar los criterios IDSA de selección de pacientes candidatos a tratamiento antibiótico a domicilio (TADE) en endocarditis?
No full textEgocentric Vision-based Action Recognition: A survey
No full text[EN] The egocentric action recognition EAR field has recently increased its popularity due to the affordable and lightweight wearable cameras available nowadays such as GoPro and similars. Therefore, the amount of egocentric data generated has increased, triggering the interest in the understanding of egocentric videos. More specifically, the recognition of actions in egocentric videos has gained popularity due to the challenge that it poses: the wild movement of the camera and the lack of context make it hard to recognise actions with a performance similar to that of third-person vision solutions. This has ignited the research interest on the field and, nowadays, many public datasets and competitions can be found in both the machine learning and the computer vision communities. In this survey, we aim to analyse the literature on egocentric vision methods and algorithms. For that, we propose a taxonomy to divide the literature into various categories with subcategories, contributing a more fine-grained classification of the available methods. We also provide a review of the zero-shot approaches used by the EAR community, a methodology that could help to transfer EAR algorithms to real-world applications. Finally, we summarise the datasets used by researchers in the literature.We gratefully acknowledge the support of the Basque Govern-ment's Department of Education for the predoctoral funding of the first author. This work has been supported by the Spanish Government under the FuturAAL-Context project (RTI2018-101045-B-C21) and by the Basque Government under the Deustek project (IT-1078-16-D)
Advanced Flame Retardant Strategies and Fire Performance Assessment for Safer Photovoltaics in Buildings: A Two-Part Review
No full textPublisher Copyright: © 2025 The Author(s). Advanced Functional Materials published by Wiley-VCH GmbH.As global decarbonization accelerates the need for extensive solar photovoltaic deployment, land-use conflicts have become increasingly pressing. Integrating PV into the built environment emerges as an effective strategy to mitigate these challenges by generating electricity where it is consumed. However, the polymeric encapsulant—a core material in photovoltaic (PV) modules—introduces critical fire safety concerns, particularly in building applications with strict regulatory requirements. This review addresses the issue with a dual approach. First, it presents various solutions to mitigate fire hazards, such as the incorporation of flame retardants, and defines five families of the latter solutions. Despite the central role of the encapsulant in module flammability, little research has focused on the use of flame retardants in photovoltaic modules. Then, a review of the existing standards and testing approaches that can be used for the assessment of building-integrated photovoltaic fire safety is presented. Based on the findings, a methodology for the evaluation of the fire performance is also proposed, with this framework evaluated at both the material and module levels.Peer reviewe
Smart cities survey: Technologies, application domains and challenges for the cities of the future
No full textPublisher Copyright: © The Author(s) 2019.The introduction of the Information and Communication Technologies throughout the last decades has created a trend of providing daily objects with smartness, aiming to make human life more comfortable. The paradigm of Smart Cities arises as a response to the goal of creating the city of the future, where (1) the well-being and rights of their citizens are guaranteed, (2) industry and (3) urban planning is assessed from an environmental and sustainable viewpoint. Smart Cities still face some challenges in their implementation, but gradually more research projects of Smart Cities are funded and executed. Moreover, cities from all around the globe are implementing Smart City features to improve services or the quality of life of their citizens. Through this article, (1) we go through various definitions of Smart Cities in the literature, (2) we review the technologies and methodologies used nowadays, (3) we summarise the different domains of applications where these technologies and methodologies are applied (e.g. health and education), (4) we show the cities that have integrated the Smart City paradigm in their daily functioning and (5) we provide a review of the open research challenges. Finally, we discuss about the future opportunities for Smart Cities and the issues that must be tackled in order to move towards the cities of the future.We gratefully acknowledge the support of the Basque Governments Department of Education for the predoctoral funding of some of the authors. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work has been supported by the Spanish Government under the FuturAAL-Ego project: RTI2018-101045-A-C22 and by the Basque Government under the Deustek project: IT-1078-16-D.Peer reviewe
Documento de consenso para el manejo de la esquistosomiasis en atención primaria
No full textHuman schistosomiasis is the parasitic disease with the highest morbidity and mortality worldwide after malaria. It is endemic in more than 78 tropical and subtropical countries, especially in sub-Saharan Africa, and it is estimated that 236 million people are infected. It can cause serious health complications at the genitourinary and hepatosplenic level, leading to the death of 300,000 people each year. The number of imported cases in Western countries has increased in recent years due to the arrival of a significant number of migrants from endemic regions and a growing number of travelers who have visited them. On the other hand, outbreaks of autochthonous transmission have recently been reported in Corsica (France) and Almería (Spain). For all these reasons, the European health authorities have recommended serological screening for the disease in all migrants from endemic areas who have been living in Europe for less than 5 years. Since Primary Care is usually the first point of contact for these people with the Health System, doctors must know the main aspects of the disease, and be provided with the necessary means for its diagnosis and treatment. This document has been prepared by professionals belonging to five scientific societies of Primary Care (SEMFyC, SEMG, SEMERGEN), Pediatrics (SEIP) and Tropical Medicine and International Health (SEMTSI), in order to establish clear recommendations for the diagnosis and management of schistosomiasis in Primary Care
Table_1_Dysautonomia in COVID-19 Patients: A Narrative Review on Clinical Course, Diagnostic and Therapeutic Strategies.DOCX
No full textIntroductionOn March 11, 2020, the World Health Organization sounded the COVID-19 pandemic alarm. While efforts in the first few months focused on reducing the mortality of infected patients, there is increasing data on the effects of long-term infection (Post-COVID-19 condition). Among the different symptoms described after acute infection, those derived from autonomic dysfunction are especially frequent and limiting.ObjectiveTo conduct a narrative review synthesizing current evidence of the signs and symptoms of dysautonomia in patients diagnosed with COVID-19, together with a compilation of available treatment guidelines.ResultsAutonomic dysfunction associated with SARS-CoV-2 infection occurs at different temporal stages. Some of the proposed pathophysiological mechanisms include direct tissue damage, immune dysregulation, hormonal disturbances, elevated cytokine levels, and persistent low-grade infection. Acute autonomic dysfunction has a direct impact on the mortality risk, given its repercussions on the respiratory, cardiovascular, and neurological systems. Iatrogenic autonomic dysfunction is a side effect caused by the drugs used and/or admission to the intensive care unit. Finally, late dysautonomia occurs in 2.5% of patients with Post-COVID-19 condition. While orthostatic hypotension and neurally-mediated syncope should be considered, postural orthostatic tachycardia syndrome (POTS) appears to be the most common autonomic phenotype among these patients. A review of diagnostic and treatment guidelines focused on each type of dysautonomic condition was done.ConclusionSymptoms deriving from autonomic dysfunction involvement are common in those affected by COVID-19. These symptoms have a great impact on the quality of life both in the short and medium to long term. A better understanding of the pathophysiological mechanisms of Post-COVID manifestations that affect the autonomic nervous system, and targeted therapeutic management could help reduce the sequelae of COVID-19, especially if we act in the earliest phases of the disease.</p
Treatment and prevention of monkeypox.
No full text20.500.12530/87857Monkeypox is a zoonosis that is spread mainly through direct contact with fluids and skin lesions of infected people with vesicles still active. Although the virus was isolated for the first time in 1958 and the first human case was identified in a child in 1970, in the Democratic Republic of the Congo, the disease has progressively increased its incidence in Africa reaching in May 2022 sustained transmission outside this continent. As it is a newly introduced virus in our health system, it is necessary to learn the epidemiological pattern in a different environment from that of traditionally endemic areas and to know the available antiviral treatments, as well as the prophylactic measures that could be considered, knowing that as a virus emerging in our regions, scientific evidence is still limited. There are antivirals that have been shown, in animal models, to effectively combat the disease with very good clinical tolerance. This disease has also forced us to review the characteristics of smallpox vaccines, because they have shown a protective effect against monkeypox. For this reason, it is important to have a document that compiles all the scientific information published in this regard
Dysautonomia in COVID-19 patients: a narrative review on clinical course, diagnostic and therapeutic strategies
No full textIntroductionOn March 11, 2020, the World Health Organization sounded the COVID-19 pandemic alarm. While efforts in the first few months focused on reducing the mortality of infected patients, there is increasing data on the effects of long-term infection (Post-COVID-19 condition). Among the different symptoms described after acute infection, those derived from autonomic dysfunction are especially frequent and limiting. ObjectiveTo conduct a narrative review synthesizing current evidence of the signs and symptoms of dysautonomia in patients diagnosed with COVID-19, together with a compilation of available treatment guidelines. ResultsAutonomic dysfunction associated with SARS-CoV-2 infection occurs at different temporal stages. Some of the proposed pathophysiological mechanisms include direct tissue damage, immune dysregulation, hormonal disturbances, elevated cytokine levels, and persistent low-grade infection. Acute autonomic dysfunction has a direct impact on the mortality risk, given its repercussions on the respiratory, cardiovascular, and neurological systems. Iatrogenic autonomic dysfunction is a side effect caused by the drugs used and/or admission to the intensive care unit. Finally, late dysautonomia occurs in 2.5% of patients with Post-COVID-19 condition. While orthostatic hypotension and neurally-mediated syncope should be considered, postural orthostatic tachycardia syndrome (POTS) appears to be the most common autonomic phenotype among these patients. A review of diagnostic and treatment guidelines focused on each type of dysautonomic condition was done. ConclusionSymptoms deriving from autonomic dysfunction involvement are common in those affected by COVID-19. These symptoms have a great impact on the quality of life both in the short and medium to long term. A better understanding of the pathophysiological mechanisms of Post-COVID manifestations that affect the autonomic nervous system, and targeted therapeutic management could help reduce the sequelae of COVID-19, especially if we act in the earliest phases of the disease
